| Symbol |
Name |
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
AFP
|
alpha-fetoprotein
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
AR
|
androgen receptor
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1
|
|
ATXN1
|
ataxin 1
|
|
AURKB
|
aurora kinase B
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
CA9
|
carbonic anhydrase IX
|
|
CACYBP
|
calcyclin binding protein
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD24
|
CD24 molecule
|
|
CD28
|
CD28 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CISD2
|
CDGSH iron sulfur domain 2
|
|
CLDN1
|
claudin 1
|
|
CLDN2
|
claudin 2
|
|
CLIC1
|
chloride intracellular channel 1
|
|
CRTC3
|
CREB regulated transcription coactivator 3
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSL
|
cathepsin L
|
|
CTTN
|
cortactin
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2W1
|
cytochrome P450, family 2, subfamily W, polypeptide 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DNM2
|
dynamin 2
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
EDN1
|
endothelin 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EFNA1
|
ephrin-A1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPHA2
|
EPH receptor A2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAM162A
|
family with sequence similarity 162, member A
|
|
FCGBP
|
Fc fragment of IgG binding protein
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
GLS
|
glutaminase
|
|
GPC3
|
glypican 3
|
|
GRAMD4
|
GRAM domain containing 4
|
|
GRN
|
granulin
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HPSE
|
heparanase
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IFNA1
|
interferon, alpha 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
JUP
|
junction plakoglobin
|
|
KDR
|
kinase insert domain receptor
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LDHA
|
lactate dehydrogenase A
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM5
|
minichromosome maintenance complex component 5
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFSD2A
|
major facilitator superfamily domain containing 2A
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MINA
|
MYC induced nuclear antigen
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR101-2
|
microRNA 101-2
|
|
MIR126
|
microRNA 126
|
|
MIR15A
|
microRNA 15a
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR181C
|
microRNA 181c
|
|
MIR203A
|
microRNA 203a
|
|
MIR204
|
microRNA 204
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR32
|
microRNA 32
|
|
MIR34B
|
microRNA 34b
|
|
MIR34C
|
microRNA 34c
|
|
MIR485
|
microRNA 485
|
|
MIR497
|
microRNA 497
|
|
MIR519A1
|
microRNA 519a-1
|
|
MIR519A2
|
microRNA 519a-2
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSH2
|
mutS homolog 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
PARK7
|
parkinson protein 7
|
|
PAX3
|
paired box 3
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIWIL1
|
piwi-like RNA-mediated gene silencing 1
|
|
PIWIL4
|
piwi-like RNA-mediated gene silencing 4
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PML
|
promyelocytic leukemia
|
|
PODXL
|
podocalyxin-like
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PROM1
|
prominin 1
|
|
PSCA
|
prostate stem cell antigen
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
RAB27B
|
RAB27B, member RAS oncogene family
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RHOA
|
ras homolog family member A
|
|
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6
|
|
RSF1
|
remodeling and spacing factor 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
SCGB2A2
|
secretoglobin, family 2A, member 2
|
|
SEPN1
|
selenoprotein N, 1
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFN
|
stratifin
|
|
SGOL1
|
shugoshin-like 1 (S. pombe)
|
|
SHBG
|
sex hormone-binding globulin
|
|
SIK3
|
SIK family kinase 3
|
|
SIX1
|
SIX homeobox 1
|
|
SLC25A43
|
solute carrier family 25, member 43
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPM3
|
tropomyosin 3
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YBX1
|
Y box binding protein 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
